News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Houthi Armed Forces Join Middle East Conflict, Two Oil Futures Surge Over 3%; Analysts Predict Tesla and SpaceX May Complete Merger in 2027 (March 30, 2026)2Even a "ceasefire" does not mean "normalization," the world in 2026 will be more "stagflated" than expected3Iran Oil Waiver Releases 140 Million Barrels to Ease Price Pressure—Yet Boosts Iran’s Revenue, Heightening Risks for Market Balance
Canadian Natural Resources: Fourth Quarter Earnings Overview
101 finance·2026/03/05 10:45
ARK's $14.5M Amazon Bet vs. $31M Roku Exit: A Flow Comparison
101 finance·2026/03/05 10:33
USA Rare Earth Set to Acquire Remaining Interest in Round Top Deposit
101 finance·2026/03/05 10:30
Nvidia collaborator Hon Hai sees a 22% increase in sales amid worldwide AI expansion
101 finance·2026/03/05 10:30
Global Liquidity and Asset Allocation Amid Geopolitical Tensions
汇通财经·2026/03/05 10:23
Two Russian Urals oil tankers reroute 14 million barrels to ports in India
101 finance·2026/03/05 10:21
Flash
13:56
Cardano founder invests $200 million to support Midnight launchThe privacy blockchain Midnight within the Cardano ecosystem has been launched, aiming to simplify blockchain usage and enhance security by concealing sensitive data. This project is backed by a $200 million investment from Cardano founder Charles Hoskinson and seeks to address core issues in cryptocurrency design.
13:54
Empery Digital reduced its holdings by 79 bitcoins last week.On March 30, Empery Digital disclosed that last week it sold 79 Bitcoin at an average price of $71,031, with total proceeds of approximately $5.6 million, reducing its Bitcoin holdings to 3,359. In addition, the company has spent about $137 million to repurchase 23,630,147 ordinary shares and plans to continue selling Bitcoin to fund share repurchases and repay part of its debt.
13:54
United Therapeutics announced that its inhaled drug Tyvaso has successfully met the primary endpoint in a late-stage clinical trial for idiopathic pulmonary fibrosis.Boosted by this positive news, the company's stock price rose sharply by 14.71%.
News